SignatureFD’s Arcutis Biotherapeutics ARQT Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $30K | Sell |
2,137
-1,413
| -40% | -$19.8K | ﹤0.01% | 1865 |
|
2025
Q1 | $55.5K | Buy |
3,550
+55
| +2% | +$860 | ﹤0.01% | 1503 |
|
2024
Q4 | $48.7K | Hold |
3,495
| – | – | ﹤0.01% | 1595 |
|
2024
Q3 | $32.5K | Hold |
3,495
| – | – | ﹤0.01% | 1812 |
|
2024
Q2 | $32.5K | Sell |
3,495
-24
| -0.7% | -$223 | ﹤0.01% | 1730 |
|
2024
Q1 | $34.9K | Buy |
+3,519
| New | +$34.9K | ﹤0.01% | 1728 |
|
2023
Q4 | – | Sell |
-346
| Closed | -$1.84K | – | 3124 |
|
2023
Q3 | $1.84K | Sell |
346
-22
| -6% | -$117 | ﹤0.01% | 2786 |
|
2023
Q2 | $3.51K | Buy |
368
+250
| +212% | +$2.38K | ﹤0.01% | 2630 |
|
2023
Q1 | $1.3K | Sell |
118
-174
| -60% | -$1.91K | ﹤0.01% | 2922 |
|
2022
Q4 | $4.32K | Sell |
292
-44
| -13% | -$651 | ﹤0.01% | 2536 |
|
2022
Q3 | $6K | Sell |
336
-49
| -13% | -$875 | ﹤0.01% | 2303 |
|
2022
Q2 | $8K | Buy |
385
+93
| +32% | +$1.93K | ﹤0.01% | 2201 |
|
2022
Q1 | $6K | Buy |
292
+282
| +2,820% | +$5.8K | ﹤0.01% | 2371 |
|
2021
Q4 | $0 | Sell |
10
-585
| -98% | – | ﹤0.01% | 3094 |
|
2021
Q3 | $14K | Buy |
+595
| New | +$14K | ﹤0.01% | 1894 |
|